| Meredith Farley, LAT, ATC, SCAT | |
|
5130 Nw Cabarrus Dr, Concord, NC 28027-7624 | |
| (704) 223-0064 | |
| Not Available |
| Full Name | Meredith Farley |
|---|---|
| Gender | Female |
| Speciality | Specialist/technologist - Athletic Trainer |
| Location | 5130 Nw Cabarrus Dr, Concord, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164136743 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Farley, LAT, ATC, SCAT 5130 Nw Cabarrus Dr, Concord, NC 28027-7624 Ph: () - | Meredith Farley, LAT, ATC, SCAT 5130 Nw Cabarrus Dr, Concord, NC 28027-7624 Ph: (704) 223-0064 |
News Archive
Jackson, Mich., resident Terrence Hicks and Detroit residents Muhammed Al Mahdi and John Saunders pleaded guilty in U.S. District Court in the Eastern District of Michigan this week for their roles in a $4.2 million Medicare fraud scheme, Assistant Attorney General Lanny A. Breuer of the Criminal Division, Acting U.S. Attorney Terrence Berg of the Eastern District of Michigan, Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office and Daniel R. Levinson, Inspector General of the Department of Health and Human Services (HHS) announced today.
Women's hormonal cycles may not only make them more prone to drug addiction but also more affected by triggers that lead to relapse, a new Vanderbilt University study revealed. The findings are especially significant since there are virtually no addiction studies in women that account for these cycles.
The University of Minnesota and Mayo Clinic, under the mantle of the Minnesota Partnership for Biotechnology and Medical Genomics, have formed a strategic research relationship with the Karolinska Institute of Stockholm, Sweden, the top-rated medical research university in Europe. Leaders of each institution signed memoranda of understanding to commit to the formal ongoing collaboration, called the Frontiers of Biomedical Research.
A consortium of federal agencies and nongovernmental organizations has published a report proposing a set of common measures and data-collection methods for use in asthma clinical research.
The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).
› Verified 4 days ago